Joshua Gans' Newsletter • 0 implied HN points • 27 Oct 23
- Immunity evolution is changing our approach to COVID-19 exposure and risk assessment. It's no longer a novel virus for most people, but individuals with weak immune systems still face risks.
- Vaccine effectiveness may be impacted by the evolution of the virus. Boosters are recommended for enhanced protection, especially for older individuals or those who are immunocompromised.
- Rapid tests may not serve as early warnings for infectiousness due to the virus's familiarity. Symptoms now provide key information, and rapid tests help determine the safety of interacting with others as symptoms lessen.